189.30
Real-Time Quote
 -0.14 / -0.07%
Today’s Change
88.34
Today|||52-Week Range
192.98
+70.42%
Year-to-Date
AbbVie Q3 Earnings Top on Humira Sales, Boosts Outlook - Analyst Blog
11:21am / Zacks.com
Allergan Issues Comment on Valeant Letter
Oct 27 / Benzinga
Cramer on the Stock Market: Find the Best of Best-of-Breed Stocks
10:56am / TheStreet.com
Valeant willing to raise offer for Botox maker Allergan
Oct 27 / FT.com
Eli Lilly/Boehringer Ingelheim Restructure Diabetes Deal - Analyst Blog
2:41am / Zacks.com
Stock Market Today: Energy Tumbles on Goldman Downgrade, Pending Home Sales Disappoin...
Oct 27 / TheStreet.com
Sanofi Beats on Q3 Earnings but Lantus Outlook Disappoints - Analyst Blog
Oct 30 / Zacks.com
UPDATE: Allergan Posts Upbeat Q3 Earnings, Lifts Forecast
Oct 27 / Benzinga
Charles River (CRL) Beats on Q3 Earnings, Guidance Upped - Analyst Blog
Oct 30 / Zacks.com
Frontrunning: October 27
Oct 27 / Investing Channel
Find the Best of Best-of-Breed Stocks
Oct 30 / TheStreet.com
Pre-Market Activity Shows Gains For Allergan (AGN)
Oct 27 / TheStreet.com
Express Scripts Reports In-Line Q3 Earnings, Narrows View - Analyst Blog
Oct 29 / Zacks.com
Allergan (AGN) Stock Higher Today After Possible New Valeant Pharmaceuticals (VRX) Bi...
Oct 27 / TheStreet.com
Novartis (NVS) Beats on Q3 Earnings, Revenues; Keeps View - Analyst Blog
Oct 29 / Zacks.com
Stock Market Today: Stock Futures Fall After Biggest Weekly Rally of 2014
Oct 27 / TheStreet.com
3 Health Care Picks To Beat Earnings - Earnings ESP
Oct 29 / Zacks.com
October 27 Premarket Briefing: 10 Things You Should Know
Oct 27 / TheStreet.com
McKesson Beats on Q2 Earnings, Revenues; Keeps Guidance - Analyst Blog
Oct 29 / Zacks.com
Earnings Scheduled For October 27, 2014
Oct 27 / Benzinga
Gilead Beats on Q3 Earnings, Sovaldi Sales Fall Sequentially - Analyst Blog
Oct 29 / Zacks.com
Stocks: 4 things to know before the open
Oct 27 / CNNMoney.com
Pfizer Q3 Earnings Top Estimates Despite Generic Pressure - Analyst Blog
Oct 28 / Zacks.com
Keep an Eye on These 7 Stocks for October 27, 2014
Oct 27 / Benzinga
Allergan (AGN) Earnings Report: Q3 2014 Conference Call Transcript
Oct 28 / TheStreet.com
J&J and Glaxo Ready to Collaborate for Ebola Vaccine Work - Analyst Blog
Oct 24 / Zacks.com
Stock Market News for October 28, 2014 - Market News
Oct 28 / Zacks.com
Glaxo Gains on Q3 Earnings Beat and Restructuring Plans - Analyst Blog
Oct 24 / Zacks.com
Jim Cramer's Top Stock Picks: CME AGN UNFI SYK
Oct 28 / TheStreet.com
Eli Lilly's Q3 Earnings In-Line but Generics Hit Revenues - Analyst Blog
Oct 24 / Zacks.com
How to Trade the Market's Most-Active Stocks
Oct 28 / TheStreet.com
Valeant (VRX) Beats Earnings Estimates in Q3, Shares Gain - Analyst Blog
Oct 23 / Zacks.com
Benzinga's M&A Chatter for Monday October 27, 2014
Oct 27 / Benzinga
Abbott Labs' (ABT) Earnings Up Y/Y in Q3, Guidance Updated - Analyst Blog
Oct 22 / Zacks.com
Markets Virtually Flat, Oil Continues To Decline Following Bearish Outlook
Oct 27 / Benzinga
Valeant Pharmaceuticals Makes Its Case With an Earnings Beat
Oct 21 / MotleyFool.com
AstraZeneca's Lynparza a Step Closer to European Approval - Analyst Blog
Oct 27 / Zacks.com
Sanofi and Regeneron Dose Patients in Dupilumab Study - Analyst Blog
Oct 20 / Zacks.com
Valeant Raises Allergan Takeover Bid
Oct 27 / Benzinga
IBM weighs heavily on the Dow
Oct 20 / FT.com
Stock Market Today: Oil Drives Stocks Lower as Goldman Sees Crude at $74 a Barrel
Oct 27 / TheStreet.com
Allergan, Inc. (AGN): New Analyst Report from Zacks Equity Research - Zacks Equity Re...
Oct 20 / Zacks.com
Merck Tops on Q3 Earnings, Patent Expiries Hit Revenues - Analyst Blog
Oct 27 / Zacks.com
Valeant hints at higher bid for Allergan
Oct 20 / FT.com
Valeant Pharmaceuticals Eyes Raising Allergan Bid to $200 a Share
Oct 27 / TheStreet.com
Healthcare Stocks in Focus on Ebola Fears - Analyst Blog
Oct 17 / Zacks.com
Allergan Beats on Earnings, Revenues; Valeant Raises Offer - Analyst Blog
Oct 27 / Zacks.com
Roche Reports Strong Sales Results for 9 Months of 2014 - Analyst Blog
Oct 17 / Zacks.com
Shire (SHPG) Gains on Q3 Earnings Beat, Ups Guidance - Analyst Blog
Oct 27 / Zacks.com
Bill Ackman's Pershing Square fizzles on IPO
Oct 13 / FT.com

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.